Is propofol the perfect hypnotic agent for procedural sedation in neonates?

Current Clinical Pharmacology

Volumn 4, Issue 2, 2009, Pages 84-86

  Allegaert, Karel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Developmental pharmacology; Neonate; Pharmacokinetics; Propofol

Indexed keywords

CREATINE; HYPNOTIC SEDATIVE AGENT; PARACETAMOL; PROPOFOL; TRAMADOL;

AGE; BODY WEIGHT; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG CLEARANCE; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG HYDROXYLATION; DRUG INTERMITTENT THERAPY; GESTATIONAL AGE; HUMAN; INTRASPECIFIC VARIATION; MEDICAL PARAMETERS; NEWBORN; NEWBORN CARE; PEDIATRIC ANESTHESIA; POSTMENSTRUAL AGE; POSTNATAL AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SEDATION; SINGLE DRUG DOSE;

AGE FACTORS; CLINICAL TRIALS AS TOPIC; GLUCURONIDES; HUMANS; HYDROXYLATION; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; PROPOFOL;

EID: 68449091260     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488409788184927     Document Type: Review

References (14)

1. Tibboel D, Anand KJ, van den Anker JN. The pharmacological treatment of neonatal pain. Semin Fetal Neonatal Med 2005; 10: 195-205.
2. Meakin G. Role of propofol in paediatric anaesthetic practice. Paediatr Anaesth 1995; 5: 147-9.
3. Hill M, Peat W, Courtman S. A national survey of propofol infusion use by paediatric anaesthetists in Great Britain and Ireland. Paediatr Anaesth 2008; 18: 488-93.
4. Playfor SD. Analgesia and sedation in critically ill children. Arch Dis Child Educ Pract Ed 2008; 93: 87-92.
5. Wolf AR, Potter F. Propofol infusion in children: when does an anesthetic tool become an intensive care liability ? Paediatr Anaesth 2004; 14: 435-8.
6. Ghanta S, Abdel-Latif ME, Lui K, Ravindranathan H, Awad J, Oei J. Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics 2007; 119: e1248-55.
7. Papoff P, Mancuso M, Caresta E, Moretti C. Effectiveness and safety of propofol in newborn infants. Pediatrics 2008; 121: 448-9.
8. Veyckemans F. Propofol for intubation of the newborn? Paediatr Anaesth 2001, 11: 630-1.
9. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kaufman RE. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 1157-67.
10. Sneyd JR, Simons PJ, Wright B. Use of proton nmr spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient. Xenobiotica 1994; 24: 1021-8.
11. Allegaert K, Vanhole C, Vermeersch S, Rayyan M, Verbesselt R, de Hoon J. Both postnatal and postmenstrual age contribute to the interindividual variability in tramadol glucuronidation in neonates. Early Hum Dev 2008; 84: 325-30.
12. Allegaert K, de Hoon J, Verbesselt R, Naulaers G, Murat I. Maturational pharmacokinetics of single intravenous bolus administration of propofol. Paediatr Anaesth 2007; 17: 1028-34.
13. Allegaert K, Peeters MY, Verbesselt R, et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007; 99: 864-70.
14. Allegaert K, Vancraeynest J, Rayyan M, et al. Urinary propofol metabolites in early life after single intravenous bolus. Br J Anaesth 2008; 101: 827-31.